Last week was a big one for U.S. cannabis companies, with several leading multistate operators (MSOs) posting their fourth-quarter earnings results. Three leading MSOs — Green Thumb Industries (OTC: GTBIF), Trulieve Cannabis (OTC: TCNNF), and Cresco Labs (OTC: CRLBF) — all beat revenue and earnings expectations handily.
Yet each cannabis stock was down for the week, some materially so. That was despite not only good company results, but also positive developments on U.S. federal and state regulations. So is the post-earnings dip a buying opportunity for these companies?